In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis
- PMID: 8585750
- PMCID: PMC162989
- DOI: 10.1128/AAC.39.11.2577
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis
Abstract
Moderately penicillin-resistant Neisseria meningitidis was responsible for an outbreak of meningococcal disease in Saskatoon, Saskatchewan, Canada in 1993. We tested fully susceptible and moderately resistant strains of N. meningitidis against ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, penicillin, and rifampin. Eighteen percent of the isolates were moderately resistant to penicillin (MIC > or = 0.06 microgram/ml) whereas susceptibility was 100% for the other agents tested.
Similar articles
-
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.J Med Microbiol. 2018 Jun;67(6):750-756. doi: 10.1099/jmm.0.000743. Epub 2018 May 2. J Med Microbiol. 2018. PMID: 29717974
-
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].Bull World Health Organ. 1998;76(4):393-400. Bull World Health Organ. 1998. PMID: 9803590 Free PMC article.
-
Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99.Diagn Microbiol Infect Dis. 2001 Sep-Oct;41(1-2):83-8. doi: 10.1016/s0732-8893(01)00289-9. Diagn Microbiol Infect Dis. 2001. PMID: 11687319
-
Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention.Indian J Med Microbiol. 2006 Jan;24(1):7-19. doi: 10.4103/0255-0857.19888. Indian J Med Microbiol. 2006. PMID: 16505549 Review.
-
Emergence of drug resistance. Impact on bacterial meningitis.Infect Dis Clin North Am. 1999 Sep;13(3):637-46, vii. doi: 10.1016/s0891-5520(05)70098-2. Infect Dis Clin North Am. 1999. PMID: 10470559 Review.
Cited by
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
-
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.Drugs. 2002;62(7):1041-89. doi: 10.2165/00003495-200262070-00005. Drugs. 2002. PMID: 11985490 Review.
-
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009. Drugs. 1997. PMID: 9074846 Review.
-
Fluoroquinolones in the Treatment of Meningitis.Curr Infect Dis Rep. 2003 Aug;5(4):329-336. doi: 10.1007/s11908-003-0011-0. Curr Infect Dis Rep. 2003. PMID: 12866985
-
Therapy of suspected bacterial meningitis in Canadian children six weeks of age and older.Paediatr Child Health. 2001 Mar;6(3):147-60. doi: 10.1093/pch/6.3.147. Paediatr Child Health. 2001. PMID: 20084227 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical